Literature DB >> 15862866

IgA1 is the premier serum glycoprotein recognized by human galectin-1 since T antigen (Galbeta1-->3GalNAc-) is far superior to non-repeating N-acetyl lactosamine as ligand.

S R Sangeetha1, P S Appukuttan.   

Abstract

Human heart galectin-1 (HHL) was separated by high pressure liquid chromatography from endogenous glycoproteins co-purified with it during affinity chromatography. These glycoproteins offered excellent ligands for HHL binding and were rich in T antigen (Galbeta1-->3 GalNAc-) of O-linked oligosaccharides. In enzyme linked lectin assay and hemagglutination inhibition assay, human IgA1, bovine fetuin and other O-glycosylated T antigen-bearing glycoproteins bound to the lectin efficiently in contrast to single N-acetyl lactosamine (LacNAc)-bearing N-linked oligosaccharides released from them and to IgG which is not O-glycosylated. HHL binding to IgA1 and fetuin was unaffected by removal of their N-linked oligosaccharides by alpha-mannosidase. When immobilized, O-glycosylated serum proteins but not IgG could capture HHL from its solutions. Desialylated or polymeric IgA1 was better inhibitor than monomeric IgA1. The findings suggest a possible role for galectin-1 in anchoring of microbial and cancer cells known to be rich in T antigen, in high serum IgA1 turn over and in tissue sequestering of IgA1 immune complexes especially after their microbial desialylation in IgA nephropathy and other immune complex-mediated disorders.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15862866     DOI: 10.1016/j.ijbiomac.2005.03.004

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  6 in total

1.  IgA and IgA-specific receptors in human disease: structural and functional insights into pathogenesis and therapeutic potential.

Authors:  Michelle M Gomes; Andrew B Herr
Journal:  Springer Semin Immunopathol       Date:  2006-10-17

2.  Circulating Lp(a):LDL complexes contain LDL molecules proportionate to Lp(a) size and bind to galectin-1: a possible route for LDL entry into cells.

Authors:  Vasantha Kalaivani; Padinjaradath Sankunni Appukuttan
Journal:  Lipids       Date:  2014-08-21       Impact factor: 1.880

Review 3.  Immunoglobulin Glycosylation Effects in Allergy and Immunity.

Authors:  Alexandra Epp; Kathryn C Sullivan; Andrew B Herr; Richard T Strait
Journal:  Curr Allergy Asthma Rep       Date:  2016-11       Impact factor: 4.806

Review 4.  The oncofetal Thomsen-Friedenreich carbohydrate antigen in cancer progression.

Authors:  Lu-Gang Yu
Journal:  Glycoconj J       Date:  2007-04-25       Impact factor: 2.916

5.  Galectin-1, -2, and -3 exhibit differential recognition of sialylated glycans and blood group antigens.

Authors:  Sean R Stowell; Connie M Arthur; Padmaja Mehta; Kristen A Slanina; Ola Blixt; Hakon Leffler; David F Smith; Richard D Cummings
Journal:  J Biol Chem       Date:  2008-01-23       Impact factor: 5.157

6.  Circulating galectins -2, -4 and -8 in cancer patients make important contributions to the increased circulation of several cytokines and chemokines that promote angiogenesis and metastasis.

Authors:  C Chen; C A Duckworth; B Fu; D M Pritchard; J M Rhodes; L-G Yu
Journal:  Br J Cancer       Date:  2014-01-02       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.